Previously, we demonstrated that agonists and antagonists of PKA and Epac do not have any observable effects on NB cell line migration, invasion or proliferation (S1 Appendix, S1 and S2 Figs). The gene discussed is RAPGEF4; the disease is neuroblastoma.